Comparison Overview

Teva Pharmaceuticals

VS

Merck

Teva Pharmaceuticals

124 Dvora hanevi'a, Tel-Aviv, undefined, 6944020, IL
Last Update: 2025-12-17
View Profile
Between 800 and 849
http://www.tevapharm.com

At Teva, we're proud to be a different kind of global pharmaceutical leader, one that operates across the full spectrum of innovation to reliably deliver medicines to patients worldwide. For over 120 years, our commitment to bettering health has never wavered. Every day, we challenge ourselves to push the boundaries of science, discover life-changing treatments, and deliver quality medicines. If patients have a need, we’re already working to address it. Because here, we are all in for better health. Learn more at www.tevapharm.com. Please note that adverse effects for any of our products should be reported to: [email protected] Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 29,653
Subsidiaries: 5
12-month incidents
0
Known data breaches
0
Attack type number
0
View Profile

Merck

126 E Lincoln Ave, P.O. Box 2000, Rahway, New Jersey, US, 07065
Last Update: 2025-12-09
Between 800 and 849
http://merck.us/2J2xAUh

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com. This site is intended for residents of the United States and Canada and their territories only. FLS: http://merck.us/3TKXNuZ

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 42,297
Subsidiaries: 2
12-month incidents
1
Known data breaches
1
Attack type number
2

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/teva-pharmaceuticals.jpeg
Teva Pharmaceuticals
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/merck.jpeg
Merck
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Teva Pharmaceuticals
100%
Compliance Rate
0/4 Standards Verified
Merck
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for Teva Pharmaceuticals in 2025.

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

Merck has 25.0% more incidents than the average of same-industry companies with at least one recorded incident.

Incident History — Teva Pharmaceuticals (X = Date, Y = Severity)

Teva Pharmaceuticals cyber incidents detection timeline including parent company and subsidiaries

Incident History — Merck (X = Date, Y = Severity)

Merck cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/teva-pharmaceuticals.jpeg
Teva Pharmaceuticals
Incidents

No Incident

https://images.rankiteo.com/companyimages/merck.jpeg
Merck
Incidents

Date Detected: 9/2025
Type:Breach
Blog: Blog

Date Detected: 06/2017
Type:Cyber Attack
Blog: Blog

FAQ

Teva Pharmaceuticals company demonstrates a stronger AI Cybersecurity Score compared to Merck company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Merck company has historically faced a number of disclosed cyber incidents, whereas Teva Pharmaceuticals company has not reported any.

In the current year, Merck company has reported more cyber incidents than Teva Pharmaceuticals company.

Neither Merck company nor Teva Pharmaceuticals company has reported experiencing a ransomware attack publicly.

Merck company has disclosed at least one data breach, while Teva Pharmaceuticals company has not reported such incidents publicly.

Merck company has reported targeted cyberattacks, while Teva Pharmaceuticals company has not reported such incidents publicly.

Neither Teva Pharmaceuticals company nor Merck company has reported experiencing or disclosing vulnerabilities publicly.

Neither Teva Pharmaceuticals nor Merck holds any compliance certifications.

Neither company holds any compliance certifications.

Teva Pharmaceuticals company has more subsidiaries worldwide compared to Merck company.

Merck company employs more people globally than Teva Pharmaceuticals company, reflecting its scale as a Pharmaceutical Manufacturing.

Neither Teva Pharmaceuticals nor Merck holds SOC 2 Type 1 certification.

Neither Teva Pharmaceuticals nor Merck holds SOC 2 Type 2 certification.

Neither Teva Pharmaceuticals nor Merck holds ISO 27001 certification.

Neither Teva Pharmaceuticals nor Merck holds PCI DSS certification.

Neither Teva Pharmaceuticals nor Merck holds HIPAA certification.

Neither Teva Pharmaceuticals nor Merck holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

Hitachi Vantara Pentaho Data Integration and Analytics Community Dashboard Framework prior to versions 10.2.0.4, including 9.3.0.x and 8.3.x display the full server stack trace when encountering an error within the GetCdfResource servlet.

Published
Date
2025-12-15
Updated
Date
2025-12-15
Risk Information
cvss3
Base: 5.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N
References
Description

Pentaho Data Integration and Analytics Community Dashboard Editor plugin versions before 10.2.0.4, including 9.3.0.x and 8.3.x, deserialize untrusted JSON data without constraining the parser to approved classes and methods.

Published
Date
2025-12-15
Updated
Date
2025-12-15
Risk Information
cvss3
Base: 8.8
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
References
Description

A security flaw has been discovered in CTCMS Content Management System up to 2.1.2. The impacted element is an unknown function in the library /ctcms/libs/Ct_Config.php of the component Backend System Configuration Module. The manipulation of the argument Cj_Add/Cj_Edit results in code injection. The attack can be executed remotely. The exploit has been released to the public and may be exploited.

Published
Date
2025-12-15
Updated
Date
2025-12-15
Risk Information
cvss2
Base: 5.8
Severity: LOW
AV:N/AC:L/Au:M/C:P/I:P/A:P
cvss3
Base: 4.7
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 5.1
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

A vulnerability was identified in CTCMS Content Management System up to 2.1.2. The affected element is the function Save of the file /ctcms/libs/Ct_App.php of the component Backend App Configuration Module. The manipulation of the argument CT_App_Paytype leads to code injection. Remote exploitation of the attack is possible. The exploit is publicly available and might be used.

Published
Date
2025-12-15
Updated
Date
2025-12-15
Risk Information
cvss2
Base: 5.8
Severity: LOW
AV:N/AC:L/Au:M/C:P/I:P/A:P
cvss3
Base: 4.7
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 5.1
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

Weblate is a web based localization tool. In versions prior to 5.15, it was possible to accept an invitation opened by a different user. Version 5.15. contains a patch. As a workaround, avoid leaving one's Weblate sessions with an invitation opened unattended.

Published
Date
2025-12-15
Updated
Date
2025-12-15
Risk Information
cvss4
Base: 1.0
Severity: HIGH
CVSS:4.0/AV:L/AC:H/AT:P/PR:L/UI:P/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References